Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Study to Evaluate D-1553 in Subjects With Solid Tumors [Phase 1, Phase 2]
This clinical trial update shows an ongoing Phase 1/2 study of D-1553 in adults with solid tumors, including non-small cell lung cancer and …
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing CT-P16, a bevacizumab biosimilar from Celltrion, with EU-approved Avastin in first-line treatment of metastatic or r…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC [Phase 2]
Phase 2 trial of Tusamitamab Ravtansine (SAR408701) with pembrolizumab, with or without platinum-based chemotherapy with/without pemetrexed,…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating SL-279252, a PD-1-Fc-OX40L fusion protein, in adults with advanced solid tumors or lymphomas has been completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS safety_alert · 2025-03-14Clinical Trial Update: LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
The document reports lorlatinib-associated hyperlipidemia in ALK-positive non-small cell lung cancer and notes monitoring considerations in …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial [Phase 3]
The Phase 3 VAPOR-C trial evaluating volatile anesthesia and perioperative outcomes in cancer patients has been terminated, including colon …
-
CLINICAL_TRIALS withdrawal · 2025-03-14Clinical Trial Update: Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation [Phase 1]
ClinicalTrials.gov entry indicates withdrawal of a Phase Ib study of furmonertinib in non-small cell lung cancer with EGFR exon 20 insertion…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer [Phase 3]
Phase 3 trial update on combining cemiplimab with platinum-based chemotherapy for non-small cell lung cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Tislelizumab in Addition to BACE in Patients with NSCLC [Phase 2]
Phase 2 trial evaluating adding tislelizumab to the BACE regimen in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer [Phase 2]
This is a Phase II clinical trial evaluating a combination of chemotherapy, a PD-1 inhibitor, and autologous CIK cell immunotherapy for meta…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) [Phase 3]
Phase 3 neoadjuvant trial evaluating SBRT sequential therapy with toripalimab and chemotherapy in resectable Stage II-III non-small cell lun…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of CLN-081 for non-small cell lung cancer with EGFR exon 20 mutations, and the study is …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating online adaptive stereotactic radiotherapy to eliminate planning target volume margins in centrally located early…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas [Phase 2, Phase 3]
A phase 2/3 clinical trial conducted by the University of Sao Paulo is evaluating platelet aggregability in patients with non-small cell lun…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: The Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic Approach
A completed study describing the lived experiences of individuals with early-stage non-small cell lung cancer after surgery and their signif…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung).
Clinical trial update for the FAHIC-Lung study investigating the family history of cancer in patients with non-small cell lung cancer. The s…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC [Phase 3]
A Phase 3 clinical trial evaluating AK104 in patients with unresectable locally advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS other · 2025-03-12Clinical Trial Update: A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer [Phase 2]
AK104 is in a Phase II trial for advanced non-small cell lung cancer, with the study status listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update for unresectable stage IIIA/IIIB non-small cell lung cancer; results have been posted as of March 11, 2025.
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating maintenance chemotherapy with or without local consolidative therapy in stage IV non-small cell lung cancer; the st…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Study of JMT203 in Patients With Cancer Cachexia [Phase 1]
Phase 1 trial evaluating JMT203 in cancer cachexia, including colorectal cancer and non-small cell lung cancer (also mentioning pancreatic c…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC [Phase 1, Phase 2]
Phase 1/2 trial of ATL001 in advanced unresectable or metastatic non-small cell lung cancer has been terminated, with results posted.